NGM · Drug Manufacturers - Specialty & Generic

Intercure Ltd. (INCR) Stock

$4.53 +2.03% NGM: INCR Healthcare

Valuation

MetricValue
Price$4.53
Market Cap$53.66M
P/E Ratio-4.76
P/B Ratio0.43
P/S Ratio0.74
EPS (TTM)$-0.63
52-Week High$8.45
52-Week Low$3.40
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-8.63%
ROA-5.17%
ROCE-5.72%
Gross Margin2.59%
Operating Margin2.59%
Net Margin-13.22%
Debt/Equity0.46
Current Ratio1.48

Annual Financials (USD)

Metric20212022202320242025
Revenue$220.0M$389.0M$356.0M$239.0M$270.0M
Operating Profit$28.0M$51.0M$-42.0M$-67.0M$7.0M
Net Profit$5.0M$45.0M$-62.0M$-68.0M$-36.0M
EPS$0.55$4.95$-6.80$-7.10$-3.15
Op Margin12.8%13.0%-11.7%-28.1%2.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$686.0M$958.0M$787.0M$763.0M$691.0M
Total Liabilities$227.0M$437.0M$330.0M$365.0M$294.0M
Cash$196.0M$233.0M$101.0M$78.0M$46.0M
Borrowings$109.0M$255.0M$196.0M$211.0M$183.0M

Latest News

InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds GlobeNewswire · Jun 22, 2026 InterCure Starts Review of US Medical Cannabis Opportunities; Completes Initial Closing of Botanico Acquisition MT Newswires · Jun 15, 2026 InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition GlobeNewswire · Jun 15, 2026 InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow GlobeNewswire · Apr 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$25.0M$51.0M$-54.0M$-67.0M$17.0M
Investing Cash Flow$-79.0M$-162.0M$2.0M$13.0M$-6.0M
Financing Cash Flow$3.0M$-17.0M$-21.0M$-15.0M$-19.0M
Net Cash Flow$158.0M$36.0M$-131.0M$-23.0M$-32.0M
Free Cash Flow$11.0M$32.0M$-56.0M$-71.0M$13.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.07
EV / EBITDA-6.08
FCF Yield6.64%
Quick Ratio0.97
Interest Coverage0.35
Return 1Y-33.26%
Return 3Y-39.08%
Return 5Y-83.29%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMWLAmerican Well Corporation $13.57 -4.37% -2.60 $230.81M 0.00%
ASRT $23.44 +0.30% -4.95 $151.47M 0.00%
BMEABiomea Fusion, Inc. $0.60 +2.58% -2.56 $43.39M 0.00%
CAMPCAMP4 Therapeutics Corporation $3.30 -2.65% -1.55 $207.09M 0.00%
CRDLCardiol Therapeutics Inc. $1.12 -2.61% -5.90 $135.14M 0.00%

About Intercure Ltd.

Intercure Ltd. is led by CEO Alexander Rabinovich, employs 320 people, headquartered in IL, publicly traded since 2019.

Intercure Ltd. (INCR) stock trades at $4.53 with a market capitalization of $53.66M. The stock is valued at a negative price-to-earnings (P/E) ratio of -4.76, reflecting a net loss over the last twelve months, price-to-book of 0.43, price-to-sales of 0.74. Over the past 52 weeks the stock has ranged between $3.40 and $8.45, and currently trades 46.4% below its 52-week high.

On profitability, Intercure Ltd. generates a return on equity (ROE) of -8.63% (negative, reflecting a net loss), return on capital employed of -5.72%, an operating margin of 2.59%, a net profit margin of -13.22%.

Intercure Ltd. by the numbers, 2016–2025

Between 2016 and 2025 Intercure Ltd. reported revenue of $0 rising to $270.0M. Compounded, revenue has grown 33.0% a year over five years, -11.5% over three, 13.0% over the last twelve months. Net profit was $-36.0M in 2025.

The most recent net margin is -13.22%. On a trailing twelve-month basis to Dec '25, revenue is $270.0M and net profit $-36.0M.

Borrowings rose from $2.0M to $183.0M, cash from operations was $17.0M in the latest year, positive in 4 of the last 10.

Return on equity has averaged -6.0% over five years, and was -9.1% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Intercure Ltd. (INCR) — frequently asked questions

What is Intercure Ltd. (INCR) stock price today?

Intercure Ltd. (INCR) is currently trading at $4.53, up 2.03% today.

What is INCR P/E ratio?

Intercure Ltd.'s P/E ratio is -4.76. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is INCR return on equity (ROE)?

Intercure Ltd.'s return on equity (ROE) is -8.63%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Intercure Ltd.'s market cap?

Intercure Ltd. has a market capitalization of $53.66M.

Does INCR pay a dividend?

Intercure Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does INCR carry?

Intercure Ltd. has a debt-to-equity ratio of 0.46. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is INCR's profit margin?

Intercure Ltd. reports a net profit margin of -13.22% — the share of revenue left after every cost, including tax and interest.

What sector is INCR in?

Intercure Ltd. is classified under Healthcare, in the Drug Manufacturers - Specialty & Generic industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is INCR listed on?

Intercure Ltd. trades on NGM under the ticker INCR.

What is INCR's 52-week range?

Over the last year Intercure Ltd. has traded between $3.40 and $8.45.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens INCR currently matches

On the figures above, Intercure Ltd. passes the filters for 2 of our ready-made screens, among them Penny Stocks, Micro Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Penny StocksMicro Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.